Anthony Spadaro, MD

Lakamana S, Das S, Spadaro A, Wightman R, Perrone J, Sarker A. Monitoring novel psychoactive substance trends on social media: Analysis of discussions and dashboard implementation. , Drug Alcohol Depend: 2026

Sompalle P, Sarker A, Love J, Moon J, Spadaro A, Wightman R, Torgersen J, Perrone J. Development and Validation of an Image-Based Deep Learning Tool for Identification of Xylazine-Associated Wounds. , J Addict Med: 2026

Spadaro A. Combined Medical Toxicology and Addiction Medicine Training: A Fellow's Perspective. , J Med Toxicol: 2026

Spadaro A, Kelly T, Morris J, Heeney ME Emergency Departments Need to Train and Hire More Sub-Specialists in Addiction Medicine. , AEM Educ Train: 2026

Spadaro A, Hairston J, Lakamana S, Wightman R, Love JL, Perrone J, Sarker A. Characterization of Reddit Posts About Xylazine-Associated Wounds: Qualitative Study , JMIR Dermatol, 8: 2025,e70329

Spadaro A, Calello DP, Counts CJ, Cerbini TA, Nelson LS, Greller HA Rapid transition from a continuous naloxone infusion to sublingual buprenorphine after an opioid overdose: a case series , Subst Use Addctn J: 2025

Thakrar A, Zwiebel S, Christine P, Spadaro A, Davis M, Bhatia R, Rohacs N, Xu L, Perrone J, Lowenstein M Manifestations of a Potential Xylazine Withdrawal Syndrome Among Hospitalized Patients: A Retrospective Cohort Study with Nested Case Control , Drug Alcohol Depend: 2025

Spadaro A, Nath J, Mok T, Chen C, Nelson LS, Santos C Parenteral Buprenorphine for Opioid Withdrawal , J Stud Alcohol Drugs, 86(3): 2025

Spadaro A, Perrone J, Nelson L, Greller HA Reining It In: Xylazine Overdose , Critical Decisions in Emergency Medicine, 39(5): 2025

Counts CJ, Spadaro A, Cerbini T, Krotulski AJ, Greller HA, Nelson LS, Ruck B, Calello DP An Outbreak of Synthetic Cannabinoid-Adulterated Tianeptine Products in New Jersey – A Case Series , J Med Toxicol, 21(2): 2025,253-259